400 related articles for article (PubMed ID: 20502724)
1. Recent advances in adjunctive therapy for epilepsy: focus on sodium channel blockers as third-generation antiepileptic drugs.
Vohora D; Saraogi P; Yazdani MA; Bhowmik M; Khanam R; Pillai KK
Drugs Today (Barc); 2010 Apr; 46(4):265-77. PubMed ID: 20502724
[TBL] [Abstract][Full Text] [Related]
2. Sodium Channel Blockers in the Treatment of Epilepsy.
Brodie MJ
CNS Drugs; 2017 Jul; 31(7):527-534. PubMed ID: 28523600
[TBL] [Abstract][Full Text] [Related]
3. [Newer antiepileptic drugs].
Matsuura M
No To Shinkei; 2007 Feb; 59(2):147-56. PubMed ID: 17315756
[TBL] [Abstract][Full Text] [Related]
4. Drug interactions involving the new second- and third-generation antiepileptic drugs.
Johannessen Landmark C; Patsalos PN
Expert Rev Neurother; 2010 Jan; 10(1):119-40. PubMed ID: 20021326
[TBL] [Abstract][Full Text] [Related]
5. Effects of carbamazepine, phenytoin, valproic acid, oxcarbazepine, lamotrigine, topiramate and vinpocetine on the presynaptic Ca2+ channel-mediated release of [3H]glutamate: comparison with the Na+ channel-mediated release.
Sitges M; Guarneros A; Nekrassov V
Neuropharmacology; 2007 Dec; 53(7):854-62. PubMed ID: 17904592
[TBL] [Abstract][Full Text] [Related]
6. Antiepileptic Drugs.
Abou-Khalil BW
Continuum (Minneap Minn); 2016 Feb; 22(1 Epilepsy):132-56. PubMed ID: 26844734
[TBL] [Abstract][Full Text] [Related]
7. Third-generation antiepileptic drugs: mechanisms of action, pharmacokinetics and interactions.
Luszczki JJ
Pharmacol Rep; 2009; 61(2):197-216. PubMed ID: 19443931
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of sodium channel blockers on in vitro induced epileptiform activities.
Gáll Z; Orbán-Kis K; Szilágyi T
Arch Pharm Res; 2017 Jan; 40(1):112-121. PubMed ID: 26515967
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamics and common drug-drug interactions of the third-generation antiepileptic drugs.
Stefanović S; Janković SM; Novaković M; Milosavljević M; Folić M
Expert Opin Drug Metab Toxicol; 2018 Feb; 14(2):153-159. PubMed ID: 29268032
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological management of epilepsy: recent advances and future prospects.
Johannessen Landmark C; Johannessen SI
Drugs; 2008; 68(14):1925-39. PubMed ID: 18778117
[TBL] [Abstract][Full Text] [Related]
11. Eslicarbazepine acetate: A novel agent for the adjunctive treatment of epilepsy.
Owen RT
Drugs Today (Barc); 2010 Jan; 46(1):23-31. PubMed ID: 20200693
[TBL] [Abstract][Full Text] [Related]
12. Neurological adverse events of new generation sodium blocker antiepileptic drugs. Meta-analysis of randomized, double-blinded studies with eslicarbazepine acetate, lacosamide and oxcarbazepine.
Zaccara G; Giovannelli F; Maratea D; Fadda V; Verrotti A
Seizure; 2013 Sep; 22(7):528-36. PubMed ID: 23623245
[TBL] [Abstract][Full Text] [Related]
13. Zonisamide in the treatment of epilepsy.
Holder JL; Wilfong AA
Expert Opin Pharmacother; 2011 Nov; 12(16):2573-81. PubMed ID: 21967409
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of lacosamide and classical sodium channel blocking antiepileptic drugs on sodium channel slow inactivation.
Niespodziany I; Leclère N; Vandenplas C; Foerch P; Wolff C
J Neurosci Res; 2013 Mar; 91(3):436-43. PubMed ID: 23239147
[TBL] [Abstract][Full Text] [Related]
15. Update on Antiepileptic Drugs 2019.
Abou-Khalil BW
Continuum (Minneap Minn); 2019 Apr; 25(2):508-536. PubMed ID: 30921021
[TBL] [Abstract][Full Text] [Related]
16. Vinpocetine inhibits glutamate release induced by the convulsive agent 4-aminopyridine more potently than several antiepileptic drugs.
Sitges M; Sanchez-Tafolla BM; Chiu LM; Aldana BI; Guarneros A
Epilepsy Res; 2011 Oct; 96(3):257-66. PubMed ID: 21737246
[TBL] [Abstract][Full Text] [Related]
17. Psychiatric side effects and antiepileptic drugs: Observations from prospective audits.
Stephen LJ; Wishart A; Brodie MJ
Epilepsy Behav; 2017 Jun; 71(Pt A):73-78. PubMed ID: 28551500
[TBL] [Abstract][Full Text] [Related]
18. Some common issues in the use of antiepileptic drugs.
Asconapé JJ
Semin Neurol; 2002 Mar; 22(1):27-39. PubMed ID: 12170391
[TBL] [Abstract][Full Text] [Related]
19. Sodium channel blockers as therapeutic target for treating epilepsy: recent updates.
Zuliani V; Fantini M; Rivara M
Curr Top Med Chem; 2012; 12(9):962-70. PubMed ID: 22352864
[TBL] [Abstract][Full Text] [Related]
20. Inverse Association between Sodium Channel-Blocking Antiepileptic Drug Use and Cancer: Data Mining of Spontaneous Reporting and Claims Databases.
Takada M; Fujimoto M; Motomura H; Hosomi K
Int J Med Sci; 2016; 13(1):48-59. PubMed ID: 26816494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
